Medtronic maintains that its $43 billion acquisition of Covidien and move to Ireland wasn't motivated by tax incentives, but the company is poised to save billions while the company's shareholders are left with a hefty tax of their own.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1wxOLyf
Cap comentari:
Publica un comentari a l'entrada